Incyte Corp. sell BMO Capital Markets
Start price
02.07.24
/
50%
€54.76
Target price
02.07.25
€44.72
Performance (%)
5.22%
End price
03.07.25
€57.62
Summary
This prediction ended on 03.07.25 with a price of €57.62. The SELL prediction by BMO_Capital_Markets shows the price for Incyte Corp. slightly increased by 5.22% during the runtime of the prediction. BMO_Capital_Markets has a follow-up prediction for Incyte Corp. where he still thinks Incyte Corp. is a Sell. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Incyte Corp. | -3.012% | -3.012% | 37.295% |
| iShares Core DAX® | -4,93 % | -11,98 % | -3,49 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % | 13,78 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % | 19,71 % |
| iShares S&P 500 | -2,54 % | -3,54 % | 8,88 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Incyte Corp. diskutieren
Incyte Co. (NASDAQ: INCY) had its "underperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $48.00 price target on the stock, down previously from $52.00.
Ratings data for INCY provided by MarketBeat
In the thread Trading Incyte Corp.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten